All SEC Filings :: Dermata Therapeutics, Inc. (DRMA)

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
07/14/23	UPLOAD	SEC-generated letter Documents TEXT-EXTRACT			1
07/12/23	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material			2
07/07/23	S-1	General form of registration statement for all companies including face-amount certificate companies Documents EX-5.1 EX-23.1 EX-FILING FEES			32
06/23/23	ARS	Annual report to security holders Documents ARS			133
06/23/23	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material			2
06/23/23	DEF 14A	Definitive proxy statements			50
06/12/23	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.			5
06/01/23	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documents EX-99.1			6
05/25/23	424B5	Prospectus filed pursuant to Rule 424(b)(5)			51
05/24/23	8-K	Current report filing Documents EX-4.1 EX-4.2 EX-4.3 EX-5.1 EX-10.1 EX-99.1			102

Previous
1…
6
7
8
9
10
11
12
13
14
15
…27
Next